NFE2L1 and pulmonary fibrosis: We hypothesize that targeting Nrf1/Tcf11, the major regulator of proteasome subunits expression, might constitute a promising therapeutic approach in pulmonary fibrosis by interplaying between the UPS, MMPs, and the Wnt/B-catenin pathway.